Last reviewed · How we verify
Ketorolac and remifentanil
At a glance
| Generic name | Ketorolac and remifentanil |
|---|---|
| Also known as | Toradol |
| Sponsor | Ullevaal University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Opioid-Free vs Opioid-Based Anesthesia in Bariatric Surgery (NA)
- Analysis of Clinical Effect of Subanesthetic Dose of Esketamine Combined With Hip Capsule Peripheral Nerve Block in Elderly Patients Undergoing Total Hip Arthroplasty (NA)
- ESP vs TAP in Total Laparoscopic Hysterectomy (NA)
- Erector Spinae Plane Block Versus Paravertebral Block During Non-intubated Thoracoscopic Lung Resections. (NA)
- Evaluating Pain Outcomes of Caudal vs Ilioinguinal Nerve Block in Children Undergoing Orchiopexy Repair (NA)
- Effect of Spinal Ketorolac After Acute Opioid Exposure (PHASE2)
- Evaluating Pain Outcomes of Caudal vs Ilioinguinal Nerve Block in Children Undergoing Hernia Repair (NA)
- Study of Anesthesia Techniques to Reduce Nausea and Vomiting After Jaw Corrective Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ketorolac and remifentanil CI brief — competitive landscape report
- Ketorolac and remifentanil updates RSS · CI watch RSS
- Ullevaal University Hospital portfolio CI